About Mechanisms in
Chronic Myelogenous Leukemia

Mechanisms in Chronic Myelogenous Leukemia is an online CME resource, with content developed by an expert, multidisciplinary panel of specialists.

The content on this Website is intended for medical oncologists, hematologists, stem cell transplant physicians, and other interested healthcare professionals who manage and treat with chronic myelogenous leukemia in the hematology/oncology setting.

    The purpose of this Website is to provide an e-learning resource about the mechanisms in chronic myelogenous leukemia. Each comprehensive learning module includes:
  • Text, authored by leading experts in the treatment and management of chronic myelogenous leukemia
  • Slide presentations
  • Clinical case studies
  • Medical animations
  • Physician self-evaluation questionnaires
Content Highlights
Chronic myelogenous leukemia is a myeloproliferative disease characterized by the presence of a specific cytogenetic abnormality, the Philadelphia chromosome, which is the result of a reciprocal translocation, t(9;22)(q34;q11), between the long arms of chromosomes 9 and 22

Please register to learn more

Program Faculty

Dr Hagop Kantarjian
Editorial Faculty
Dr Giuseppe Saglio
Dr Michael Mauro
Dr Jorge Cortes
Dr Michael Deininger
Dr Andreas Hochhaus
Dr Elias Jabbour

About Us Contact Us Terms of Use Privacy Policy Technical Requirements Help